Elsevier

Obstetrics & Gynecology

Volume 92, Issue 6, December 1998, Pages 1044-1055
Obstetrics & Gynecology

Review Articles
Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology

https://doi.org/10.1016/S0029-7844(98)00328-7Get rights and content

Abstract

Objective: To update basic concepts and management strategies of fetal growth restriction (FGR).

Data source: An English literature search was conducted for pertinent articles related to FGR from 1976 to 1997. Original research articles, review articles, and book chapters were reviewed.

Methods of study selection: This study was divided into two parts. For this article, both human data and animal data pertinent to understanding causative factors, pathogenesis, clinical type, and pathophysiology were included. To perform a meaningful comparison, the concept of investigators and their methods of investigation were critically compared between the two study periods: 1976–1985 and 1986–1997.

Tabulation, integration, and results: Older concepts involving basic principles of FGR based on animal models during the first study period were integrated with new research findings obtained from human FGR during the second study period. By comparative analysis of older animal data and new human data, current concepts of FGR were synthesized.

Conclusion: Fetal growth restriction affects a heterogenous group of infants. Despite development of new technology for investigation, many older basic concepts related to FGR are still fundamentally sound. However, new investigations directly performed on human fetuses are a useful expansion of the older concepts.

Section snippets

Current definition of FGR

A growth-restricted fetus is one that has not reached its growth potential at a given gestational age due to one or more causative factors. Fetal growth restriction constitutes only a fraction of small for gestational age (SGA) newborn.12 Depending on an arbitrary cutoff level, 3 to 10% of neonates weigh below the normal adjusted value for gestational age.7, 9, 12, 14, 15 Up to 70% of SGA infants are small simply due to constitutional factors determined by maternal ethnicity, parity, weight, or

Classification of FGR

Fetal growth restriction can be classified according to cell growth dynamics and clinical types. The classification of cell growth dynamics was established during the first study period. Fetal growth was viewed as having three consecutive cell growth dynamic phases.18, 19 The first phase was referred to as the phase of cellular hyperplasia occurring during the first 16 weeks of gestation. During this phase, a rapid increase in cell number occurs. The second phase was known as the phase of

Causative factors of FGR

Fetal growth restriction can be caused by fetal, placental, maternal, and other factors listed in Table 1. During the first study period, many investigators mainly focused on factors responsible for mature FGR, such as high altitude, smoking, alcohol, maternal nutritional deprivation, etc. During the second study period, investigators turned their attention to preterm FGR, especially second trimester FGR, such as genetic causes, multiple gestations, antiphospholipid antibody related maternal

Pathophysiology of FGR

Basic concepts of pathophysiology of FGR are based on different levels of maternal supply, fetoplacental competitions, and fetal adaptations (Table 2). Uterine blood flow patterns in early sheep pregnancies cannot be distinguished from those in nonpregnant animals until day 17 of gestation.53 After day 60, the same level of uterine blood flow is maintained until term. The relative proportion of uterine blood flow distributed to the placental cotyledons is approximately 20 to 30% in early

Growth promoting hormones and FGR

Insulin is one of the determinants of fetal size through its action on nutrient uptake and utilization. Insulin in the fetus directs nutrients to insulin-sensitive tissues, such as skeletal muscle, liver, and adipose tissue, which promote glycogen and fat storage. Low insulin concentrations and a blunted insulin response to an intravenous glucose load have been described in fetuses with FGR.85 Since insulin increases placental glucose transfer, low insulin levels in fetuses with FGR might be an

Vasodilators, vasoconstrictors, and FGR

Pregnancies complicated by preeclampsia or by growth-restricted infants not only demonstrate inadequate maternal vascular response to placentation, but also are found to have extensive endothelial injury.94 Vasospasm causes resistance to blood flow and accounts for the development of arterial hypertension.

Studies during the first study period indicated that normal pregnant women are refractory to the pressor effects of infused angiotensin II.95 Gant et al96, 97 demonstrated that increased

Research in progress

Our knowledge of the basic features which regulate fetal growth is expanding. In this section we will briefly review three areas of current research which appear significant for understanding the development of FGR: genes involved in the regulation of the cell cycle; interaction between immunology and human placental implantation; and the control and function of growth factors.

The relationship between the fetal genome and genetic potential for growth, which as previously mentioned, is dependent

Conclusion

This review describes current concepts of pathogenesis and pathophysiology of FGR. The basic concept of FGR has been that there is an inadequate maternal-fetal supply of oxygen and nutrients which initiates fetal adaptation measures. Older investigations used well-controlled pregnant animal experiments. These established concepts from animal data are still useful today. Current investigations on human fetuses using new technologies have resulted in a greater understanding of the pathophysiology

References (126)

  • F.G Cunningham et al.

    Chronic renal disease and pregnancy outcome

    Am J Obstet Gynecol

    (1990)
  • C.C Lin et al.

    Fetal outcome in hypertensive disorders of pregnancy

    Am J Obstet Gynecol

    (1982)
  • J.C Haworth et al.

    Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake

    Am J Obstet Gynecol

    (1980)
  • M.B Meyer

    How does maternal smoking affect birth weight and maternal weight gain?Evidence from the Ontario Perinatal Mortality Study

    Am J Obstet Gynecol

    (1978)
  • K.L Jones et al.

    Pattern of malformation in offspring of chronic alcohol mothers

    Lancet

    (1973)
  • J.W Hanson et al.

    Risks to offspring of women treated with hydantoin anticonvulsants with emphasis on the fetal hydantoin syndrome

    J Pediatr

    (1976)
  • J.G Hall et al.

    Maternal and fetal sequelae of anticoagulation during pregnancy

    Am J Med

    (1980)
  • R.L Goldenberg et al.

    Low birth weight intrauterine growth retardation and preterm delivery

    Am J Obstet Gynecol

    (1985)
  • F.C Greiss et al.

    Uterine blood flow during early ovine pregnancy

    Am J Obstet Gynecol

    (1970)
  • E.L Makowski et al.

    Distribution of uterine blood flow in pregnant sheep

    Am J Obstet Gynecol

    (1968)
  • H Schulman et al.

    Development of uterine artery compliance in pregnancy as detected by Doppler ultrasound

    Am J Obstet Gynecol

    (1986)
  • S Campbell et al.

    New Doppler technique for assessing uteroplacental blood flow

    Lancet

    (1983)
  • T Akalin-Sel et al.

    Understanding the pathophysiology of intrauterine growth retardationThe role of the “lower limb reflex” in redistribution of blood flow

    Eur J Obstet Gynecol Reprod Biol

    (1992)
  • A Fleischer et al.

    Umbilical artery velocity waveforms and intrauterine growth retardation

    Am J Obstet Gynecol

    (1985)
  • G.L Loy et al.

    Cerebral and umbilical resistance response to vibroacoustic stimulation in growth restricted fetuses

    Obstet Gynecol

    (1997)
  • C Krebs et al.

    Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree

    Am J Obstet Gynecol

    (1996)
  • M Nitzan et al.

    Hepatic gluconeogenesis and lipogenesis in experimental intrauterine growth retardation in the rat

    Am J Obstet Gynecol

    (1971)
  • J.R Humbert et al.

    Polycythemia in small for gestational age infants

    J Pediatr

    (1969)
  • C.C Lin et al.

    Acid-base characteristics of fetuses with intrauterine growth retardation during labor and delivery

    Am J Obstet Gynecol

    (1980)
  • U Nicolini et al.

    Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation

    Am J Obstet Gynecol

    (1989)
  • D.L Economides et al.

    Blood glucose and oxygen tension levels in small-for-gestational-age fetuses

    Am J Obstet Gynecol

    (1989)
  • D.L Economides et al.

    Plasma amino acids in appropriate and small-for-gestational-age fetuses

    Am J Obstet Gynecol

    (1989)
  • F.A Van Assche et al.

    The fetal endocrine pancreas

    Eur J Obstet Gynecol Reprod Biol

    (1984)
  • V.A Khouzami et al.

    The glucose tolerance test as a means of identifying intrauterine growth retardation

    Am J Obstet Gynecol

    (1981)
  • R.J Sokol et al.

    Identifying the pregnancy at risk for intrauterine growth retardationPossible usefulness of the intravenous glucose tolerance test

    Am J Obstet Gynecol

    (1982)
  • O Langer et al.

    A link between hypoglycemia-hypoinsulinemia during oral glucose tolerance tests and intrauterine growth retardation

    Am J Obstet Gynecol

    (1986)
  • C.C Lin et al.

    Amniotic fluid C-peptide as an index for intrauterine fetal growth

    Am J Obstet Gynecol

    (1981)
  • D.R Shanklin et al.

    Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels

    Am J Obstet Gynecol

    (1989)
  • R Abdul-Karim et al.

    Pressor response to angiotonin in pregnant and nonpregnant women

    Am J Obstet Gynecol

    (1961)
  • S.W Walsh

    PreeclampsiaAn imbalance in placenta prostacyclin and thromboxane production

    Am J Obstet Gynecol

    (1985)
  • L.O Lubchenco et al.

    Intrauterine growth as estimated from live birth weight data at 24 to 42 weeks of gestation

    Pediatrics

    (1963)
  • C.C Lin et al.

    Intrauterine growth retardationPathophysiology and clinical management

    (1984)
  • C.C Lin

    Intrauterine growth retardation

  • C.C Lin

    Pathophysiology of perinatal hypoxia in fetuses with intrauterine growth retardation

  • C.C Lin

    Perinatal hypoxia in the growth retarded fetusbasic pathophysiology and clinical management

  • A Kurjak et al.

    Fetal growth retardationdiagnosis and treatment

    (1989)
  • R.N Pollack et al.

    Intrauterine growth retardationdefinition, classification, and etiology

    Clin Obstet Gynecol

    (1992)
  • C.C Lin

    Fetal growth retardation

  • F.G Cunningham et al.
  • S.G Gabbe

    Intrauterine growth retardation

  • Cited by (133)

    • Assessment of the blood flow in kidneys of growth-restricted fetuses using quantitative three-dimensional power Doppler ultrasound

      2018, Taiwanese Journal of Obstetrics and Gynecology
      Citation Excerpt :

      All fetuses were followed to delivery to determine whether they were born with FGR or without FGR. When their birthweights were below the 10th percentile for gestational age (GA) according to the standard [13], they were classified as fetuses with FGR. In total, 209 non-FGR fetuses and 50 FGR fetuses were included in the final analysis.

    View all citing articles on Scopus
    View full text